Catherine Do
CIK: 0002040323
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Do Catherine
Do Catherine (SEC CIK 0002040323) files insider reports with the SEC as Director of Drugs Made In America Acquisition II Corp. (DMII) and Director of Drugs Made In America Acquisition Corp. (DMAA).
Signal8 holds 4 ownership filings by Do Catherine (2 Form 3, 2 Form 4), filed between Jan 10, 2025 and Oct 17, 2025. Those filings report 2 transactions, from Jan 29, 2025 to Sep 26, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Do Catherine's filings is in FORT LAUDERDALE, FL.
Recent filings by Do Catherine
Other insiders filing for Drugs Made In America Acquisition II Corp. (DMII)
- Shulgan Myron W., Director
- Worman Glenn C., CFO
- Stockwell Lynn, CEO and Exe. Chair of Board
- Drugs Made In America Acquisition II LLC, 10% Owner
- Prasad Sridhar G., Director